Long-term safety and effectiveness of ritonavir (RTV), nelfinavir (NFV) and lopinavir/ritonavir (LPWr) in antiretroviral (ARV)-experienced HIV-1-infected children

被引：0
|
作者：
Rudin, Christoph
Burri, Marcus
Shen, Yang
Rode, Richard
Nadal, David
机构：
[1] Univ Basel, Childrens Hosp, Basel, Switzerland
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Univ Zurich, Childrens Hosp, Div Infect Dis, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2007年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [1] Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children
    Rudin, Christoph
    Burri, Marcus
    Shen, Yang
    Rode, Richard
    Nadal, David
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) : 431 - 437
  • [2] Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children
    Rudin, Christoph
    Wolbers, Marcel
    Nadal, David
    Rickenbach, Martin
    Bucher, Heiner C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (06) : 478 - 481
  • [3] Long-Term Responses to Treatment Including Ritonavir or Nelfinavir in HIV-1-Infected Children
    D. Nadal
    F. Steiner
    J.-J. Cheseaux
    C.-A. Wyler Lazarevitch
    C. Aebi
    C. Kind
    C. Rudin
    Infection, 2000, 28 : 287 - 296
  • [4] Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children
    Nadal, D
    Steiner, F
    Cheseaux, JJ
    Lazarevitch, CAW
    Aebi, C
    Kind, C
    Rudin, C
    INFECTION, 2000, 28 (05) : 287 - 296
  • [5] Long-term Lopinavir/Ritonavir Monotherapy in HIV-infected Children
    Kosalaraksa, Pope
    Ananworanich, Jintanat
    Puthanakit, Thanyawee
    Pinyakorn, Suteeraporn
    Lumbiganon, Pagakrong
    Chuanjaroen, Thongsuai
    Chobkarjing, Umaporn
    Phanuphak, Praphan
    Pancharoen, Chitsanu
    Bunupuradah, Torsak
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (04) : 350 - 353
  • [6] Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children (vol 28, pg 287, 2000)
    Nadal, D
    INFECTION, 2000, 28 (06) : 402 - 402
  • [7] Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir
    King, MS
    Brun, SC
    Kempf, DJ
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (12): : 2046 - 2052
  • [8] Predictive factors of virologic success in HIV-1-infected children treated with lopinavir/ritonavir
    Delaugerre, C
    Teglas, JP
    Treluyer, JM
    Vaz, P
    Jullien, V
    Veber, F
    Rouzioux, C
    Chaix, ML
    Blanche, SP
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (02) : 1269 - 1275
  • [9] Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children
    van der Lee, Manon
    Verweel, Gwenda
    de Groot, Ronald
    Burger, David
    ANTIVIRAL THERAPY, 2006, 11 (04) : 439 - 445
  • [10] Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children
    Fraaij, PLA
    Neubert, J
    Bergshoeff, AS
    van Rossum, AMC
    Hartwig, NG
    Schroten, H
    Korn, K
    Burger, DM
    de Groot, R
    Niehues, T
    ANTIVIRAL THERAPY, 2004, 9 (02) : 297 - 299
12345